Gemma 4 - Page 6
Stories from Gemma 4 come first, newest first, then stories from connected topics (NVIDIA Jetson, on-device AI, Nvidia, AI Models, AI), each labelled with where it comes from. This view is not indexed by search engines.
Latest
New York Plans an AI Jobs Institute to Train Up to 40,000 by 2032
New York and Pursuit are building an AI Jobs Institute in Queens with $10m of public money. It aims to train up to 40,000 people by 2032; none trained yet.
US Treasury Proposes Rule Widening Outbound Investment Curbs
A proposed US Treasury rule under the COINS Act would extend outbound investment curbs to five more countries and three more sectors. Comments close 7 Dec.
Italy’s New AI Decree Bans Fully Automated Decisions on Workers
Italy's AI decree 179/2026, in force from 23 October, says a person must make final hiring, firing and discipline decisions. Breaches are null and void.
Greece Passes Under-15 Social Media Ban, With Age Checks From 2027
Greece's parliament has banned social media for under-15s from 1 January 2027, making platforms verify ages in a way ministers say protects privacy.
South Korea to Cut Permits and Parking Rules for AI Data Centres
South Korea plans faster permits, looser building rules and a possible grid-review exemption for AI data centres outside the capital region.
Scientists Map How Andes Hantavirus Latches Onto Human Cells
Cryo-EM shows how the Andes hantavirus spike grips the PCDH1 receptor, revealing a pocket that could guide new antiviral drugs. No treatment exists yet.
Ai2 Releases Open Satellite Embeddings for Every 10m Pixel on Earth
Ai2's OlmoEarth v1.3 gives every 10-metre pixel on Earth a 128-number summary, with a free no-sign-in explorer. Its benchmark lead is self-reported.
Anthropic Says Claude Proved 239 Open-Source Entry Points Crash-Free
Anthropic and Theorem used Claude to write machine-checked proofs that 239 OSS-Fuzz entry points cannot crash, finding hundreds of bugs along the way.
Personalised mRNA Therapy Cuts Melanoma Recurrence or Death Risk 42%
In a 1,137-patient phase 3 trial, intismeran plus Keytruda cut the risk of melanoma recurrence or death by 42%. Survival data are not yet mature.
Rivian Buys Third Dimension AI to Simulate Hard Self-Driving Cases
Rivian has bought Third Dimension AI, which turns real driving footage into 3D scenes for testing self-driving software. Terms were not disclosed.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.